Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Shanghai-based biotech firm Hexaell Biotech has secured 200 million renminbi ($31 million) in a series B+ funding round. The ...

Then, mice were anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine ip), blood was collected by cardiac puncture, centrifuged, and the serum was stored at -20 °C. The liver, riWAT, and the right ...